280 related articles for article (PubMed ID: 7509670)
1. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B
Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670
[TBL] [Abstract][Full Text] [Related]
2. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
3. Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30.
Nagayama Y; Rapoport B
J Clin Endocrinol Metab; 1992 Dec; 75(6):1425-30. PubMed ID: 1361193
[TBL] [Abstract][Full Text] [Related]
4. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
McLachlan SM; Bahn R; Rapoport B
Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
6. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
Tahara K; Yamamoto K; Tamura Y; Yoshida S
Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy.
Wortsman J; McConnachie P; Tahara K; Kohn LD
J Clin Endocrinol Metab; 1998 Jul; 83(7):2302-8. PubMed ID: 9661599
[TBL] [Abstract][Full Text] [Related]
9. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
[TBL] [Abstract][Full Text] [Related]
11. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
12. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
14. Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications.
Kim WB; Chung HK; Lee HK; Kohn LD; Tahara K; Cho BY
J Clin Endocrinol Metab; 1997 Jun; 82(6):1953-9. PubMed ID: 9177413
[TBL] [Abstract][Full Text] [Related]
15. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
17. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
[TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies.
Filetti S; Foti D; Costante G; Rapoport B
J Clin Endocrinol Metab; 1991 May; 72(5):1096-101. PubMed ID: 2022709
[TBL] [Abstract][Full Text] [Related]
20. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
